A dose-escalation regimen of trimethoprim–sulfamethoxazole is tolerable for prophylaxis against Pneumocystis jiroveci pneumonia in rheumatic diseases

Kenchi Takenaka,Yoji Komiya,Mineto Ota,Hayato Yamazaki,Kenji Nagasaka

A dose-escalation regimen of trimethoprim–sulfamethoxazole is tolerable for prophylaxis against Pneumocystis jiroveci pneumonia in rheumatic diseases

2013

Kenchi Takenaka
Yoji Komiya
Mineto Ota
Hayato Yamazaki
Kenji Nagasaka

Objective To investigate the safety and efficacy of a dose-escalation regimen of trimethoprim–sulfamethoxazole (TMP/SMX) for prophylaxis against Pneumocystis jiroveci pneumonia (PCP) in rheumatic diseases.

Keywords:

Pneumocystis jiroveci pneumonia
Regimen
Trimethoprim
Physical therapy
Diabetes mellitus
Sulfamethoxazole
Intensive care medicine
Medicine
Internal medicine
dose escalation

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations